Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)
Myomo's (MYO) quarterly Liabilities and Shareholders Equity came in at $38.6 million in Q4 2025, down 8.54% YoY from $42.2 million in Q4 2024, and up 13.38% on a QoQ basis from $34.1 million in Q3 2025.
Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $38.6 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 8.54% year-over-year to $38.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.3 million (up 66.82% YoY) and the FY2025 annual result came in at $38.6 million, down 8.54% from the prior year.
- Liabilities and Shareholders Equity climbed to $38.6 million in Q4 2025, from $34.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $42.2 million in Q4 2024 to a low of $10.2 million in Q4 2022.
- A 5-year average of $21.7 million and a median of $17.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slumped 49.43% — and 2024, when it surged 189.71%.
- Tracing MYO's Liabilities and Shareholders Equity over 5 years: stood at $20.1 million in 2021, then tumbled by 49.43% to $10.2 million in 2022, then jumped by 43.49% to $14.6 million in 2023, then surged by 189.71% to $42.2 million in 2024, then decreased by 8.54% to $38.6 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $38.6 million (Q4 2025), $34.1 million (Q3 2025), and $38.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | 38.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.64 Mn |
| Sep 30, 2025 | 34.08 Mn |
| Jun 30, 2025 | 38.67 Mn |
| Mar 31, 2025 | 40.87 Mn |
| Dec 31, 2024 | 42.24 Mn |
| Sep 30, 2024 | 16.31 Mn |
| Jun 30, 2024 | 16.19 Mn |
| Mar 31, 2024 | 16.52 Mn |
| Dec 31, 2023 | 14.58 Mn |
| Sep 30, 2023 | 17.05 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 13.74 Mn |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 14.56 Mn |
| Mar 31, 2022 | 17.98 Mn |
| Dec 31, 2021 | 20.10 Mn |
| Sep 30, 2021 | 17.46 Mn |
| Jun 30, 2021 | 17.71 Mn |
| Mar 31, 2021 | 20.92 Mn |